Geometry.Net - the online learning center
Home  - Health_Conditions - Lipoid Nephrosis

e99.com Bookstore
  
Images 
Newsgroups
Page 2     21-40 of 85    Back | 1  | 2  | 3  | 4  | 5  | Next 20
A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

         Lipoid Nephrosis:     more detail

21. Lipoid Nephrosis
lipoid nephrosis. A Medical General Hospital. A resource with informationon over 4000 medical topics including lipoid nephrosis.
http://www.bloodandmarrowtransplant.com/medical-terms/01322.htm
Lipoid nephrosis
A Medical Encyclopedia Article provided by Maryland General Hospital A resource with information on over 4000 medical topics including: Lipoid nephrosis
Previous
Next

22. Minimal Change Nephropathy
Minimal Change Nephropathy A. Characteristics See outline NephroticSyndrome Commonly called lipoid nephrosis; Mainly occurs in
http://www.outlinemed.com/demo/nephrol/4857.htm
Minimal Change Nephropathy
A. Characteristics
See outline "Nephrotic Syndrome"
  • Commonly called Lipoid Nephrosis
  • Mainly occurs in young children, with male predominance
  • 76% of nephrotic syndrome in children
  • 26% of nephrotic syndrome in adults
  • Generally selective proteinuria = albumin, suggesting charge defect involved
  • Relapsing course
  • Uncommon hematuria and hypertension
    B. Pathology
    See outline "Membranous Nephropathy"
  • Minimal change on standard light microscopic evaluation
  • Lipid droplets may be seen in tubular epithelial cells
  • EM shows glomerular epithelial injury with widespread retraction of foot processes
  • During remissions, foot processes return to normal
    C. Etiology
  • Uncertain, but may be immune related
  • Suggestion of T cell dysfunction, with increased production of T suppressor cytokines
  • Some of these cytokines may be directly toxic to glomerular epithelial cells
  • Various drugs can cause disease, including NSAIDs [
    D. Therapy and Prognosis
    See outline "Rheumatologic Therapeutics"
  • Children usually do better
  • Glucocorticoid responsive cases usually do better
  • Disease will sometimes spontaneously remit
  • Glucocorticoids are major therapy, with good response
  • 23. ·?
    ? 2) WHO? 1. Primary glomerulonephritisa) Minimal change disease (lipoid nephrosis) b) Focal segmental
    http://www.clinpath.kpu-m.ac.jp/datafolder/lect/kid_gl.html

    24. Kidneys - Nephrotic Syndrome
    A range of causes Minimal change disease (lipoid nephrosis) is themost common form of nephrotic syndrome in children. Generally
    http://www.disability.vic.gov.au/dsonline/dsarticles.nsf/pages/Kidneys_nephrotic

    25. Interrelationship Between The Different Types Of The Nephrotic Syndrome
    The literature contains conflicting reports of the percentages of lipoid nephrosis(minimal changenil disease foot process 'fusion' is the only morphologic
    http://nephrotic-syndrome.org/disease/zdic2.php
    [members only] [home] [subscribe to kid_comm] [get access data] ... [forgott access data?]
    The disease
    Interrelationship

    Medical Summary

    about MCNS

    Treatment of the
    ...
    sindrome nefrosica (italiano)
    About us
    How it all began (our history)

    Persons behind the tasks

    Experiences of a mother

    Poems from and
    ... Our privacy statement Resources Description of the closed part Our mailinglists FAQ about the kid_comm list ... Our public forum Miscelanous Some general Infos (FAQs) The approvement workflow Site map external Links The nephcure foundation. A foundation who cares about to find a way to cure the nephrotic-syndrome. Conventional Therapy (English and german) Dialysis Online ... About the maker of this site "The Software Toolwork Multimedia Encyclopedia"
    Among the more serious KIDNEY DISEASES are glomerulonephritis, nephrosis, and pyelonephritis. Of the many observed forms of glomerulonephritis, most show evidence of deposits of antibody-antigen complexes in the glomeruli, the kidney's filtering units; thus one common form of the disease occurs two to three weeks after an infection of the throat or skin with streptococci. Most cases are temporary but a few become chronic, leading to kidney failure and UREMIA. Nephrosis, or nephrotic syndrome , is an outpouring of protein into the urine due to glomeruli damage. It is not itself a disease but a symptom observed at some time in the course of chronic glomerulonephritis, multiple myeloma, lupus erythematosus, or other serious diseases. Pyelonephritis is a serious infection of kidney tissue that can result in permanent damage if not treated promptly. It usually results from bacterial infections of the BLADDER (see CYSTITIS) or of the URETER, the tube ascending from the bladder to the kidney.

    26. THE LIGHTNING HYPERTEXT OF DISEASE.
    minimal change foot process disease foot, process disease disease, foot process footprocessdisease epithelial-cell disease lipoid nephrosis lipoid, nephrosis
    http://www.pathinfo.com/cgi-bin/lh.cgi?tx=nephritic

    27. EMedicine - Minimal-Change Disease : Article Excerpt By: Abeera Mansur, MD
    MinimalChange Disease - Minimal-change disease (MCD), also known as lipoid nephrosisor nil disease, is the most common single form of nephrotic syndrome in
    http://www.emedicine.com/med/byname/minimal-change-disease.htm
    (advertisement)
    Excerpt from Minimal-Change Disease
    Synonyms, Key Words, and Related Terms: MCD, idiopathic nephrotic syndrome of childhood, lipoid nephrosis, minimal-change nephropathy, minimal-change nephrotic syndrome, MCNS, nil disease, steroid-sensitive nephrotic syndrome
    Please click here to view the full topic text: Minimal-Change Disease
    Background: Minimal-change disease (MCD), also known as lipoid nephrosis or nil disease, is the most common single form of nephrotic syndrome in children. It refers to a histopathologic lesion in the glomerulus that almost always is associated with nephrotic syndrome. It typically is a disease of childhood, but it also can occur in adults. Pathophysiology: It is postulated that MCD is a disorder of T cells, which release a cytokine that injures the glomerular epithelial foot processes. This, in turn, leads to a decreased synthesis of polyanions. The polyanions constitute the normal charge barrier to the filtration of macromolecules such as albumin. When the polyanions are damaged, leakage of albumin follows. The identity of this circulating permeability factor is uncertain, although it is postulated that it may be hemopexin. Some of the cytokines that have been studied in MCD are interleukin-12 (IL-12) and interleukin-4 (IL-4). IL-12 levels have been found to be elevated in peripheral blood monocytes during the active phase and normalized during remission. Interleukin-18 (IL-18) can synergize with IL-12 to selectively increase the production of vascular permeability factor from T cells. In addition, levels of IL-4 and CD23 (a receptor for immunoglobulin E) have been found to be elevated in peripheral blood lymphocytes.

    28. Lipoid Nephrosis
    lipoid nephrosis. A Medical Arundel Hospital. A resource with informationon over 4000 medical topics including lipoid nephrosis.
    http://www.mcadd.net/medical-terms/01322.htm
    Lipoid nephrosis
    A Medical Encyclopedia Article provided by North Arundel Hospital A resource with information on over 4000 medical topics including: Lipoid nephrosis
    Previous
    Next

    29. 1Up Health > Minimal Change Disease > Causes, Incidence, And Risk Factors Of Min
    Comprehesive information on Minimal change disease (Idiopathic nephrotic syndromeof childhood, lipoid nephrosis, Minimal change nephrotic syndrome, Nil disease
    http://www.1uphealth.com/health/minimal_change_disease_info.html
    1Up Health Minimal change disease Alternative Medicine Clinical Trials ... Health Topics A-Z Search 1Up Health Minimal change disease Information Minimal change disease Causes, Incidence, and Risk Factors Alternative names : Idiopathic nephrotic syndrome of childhood, Lipoid nephrosis, Minimal change nephrotic syndrome, Nil disease Definition : A disorder of the kidneys that affects the structures (glomeruli) which include small capillaries surrounded by membranes through which the blood is filtered to form urine.
    Causes, Incidence, and Risk Factors
    Minimal change disease is one cause of nephrotic syndrome . It is named because under a light microscope the glomeruli appear totally normal. Under an electron microscope characteristic changes in the glomeruli can be seen, including the fusion of a portion of the epithelial layer.
    Minimal change disease is most common in children but occasionally occurs in adults. The cause is unknown, but the disease may be preceded by viral infection, allergic reactions or recent immunizations.
    Minimal change disease does not reduce the amount of urine produced. It rarely progresses to

    30. Untitled Document
    a. lipoid nephrosis (minimal change glomerulonephritis) b. hemolytic transfusionreaction c. crush injury with myoglobinuria d. hemorrhagic shock e. bilateral
    http://www.uic.edu/depts/mcpt/curriculum/tle10/tle10questions.html
    Questions: Acute oliguria may be seen with all of the following except: a. lipoid nephrosis (minimal change glomerulonephritis)
    b. hemolytic transfusion reaction
    c. crush injury with myoglobinuria
    d. hemorrhagic shock
    e. bilateral ureteral calculi In a consideration of adult polycystic disease of the kidney, all of the following statements are known to be true except: a. the disease if familial
    b. the disease is at times unilateral
    c. the disease is generally asymptomatic until early adult and middle life hematuria,
    d. hypotension and palpable abdominal masses are frequent clinical findings in symptomatic patients In consideration of the disease, chronic pyelonephritis, all of the following statements are correct except: a. This disease must be considered in the differential diagnosis of any patient with nephrotic syndrome.
    b. There is usually dilatation of the pelvis and calces.
    c. Patients with this disease may have small contracted kidneys late in the clinical course.

    31. Óðîâíè Èë
    Matsumoto K., Osakabe K., Katayama H., Hatano M. In vitro lymphocyte disfunctionin lipoid nephrosis mediated by suppressor cells. Nephron 1982; 32 270272.
    http://www.dialysis.ru/magazin/3_2000/il_10.htm
    IL-10, IL-8 in Serum of Children with Different Variants of Steroid-Sensitive Nephrotic Syndrome of Primary Chronic Glomerulonephritis T.V. Vashurina, T.B. Sentsova, T.V. Sergeeva g (IFN- g ) ïðîäóöèðóþòñÿ Ò-õåëïåðàìè 1 (Th 1). Èíòåðëåéêèí 4 (Èë-4) ÿâëÿåòñÿ öèòîêèíîì Òh2. Èë-10, Èë-13 ñåêðåòèðóþòñÿ â áîëüøåé ñòåïåíè Th2, â ìåíüøåé - Th0, Th1. Ñëåäîâàòåëüíî, ñîîòíîøåíèå IFN- g Ìíîãèå èññëåäîâàíèÿ ïðîäåìîíñòðèðîâàëè ïîâûøåííóþ àêòèâíîñòü êëîíà ñóïðåññîðíûõ/öèòîòîêñè÷åñêèõ êëåòîê (CD8+) è íàòóðàëüíûõ êèëëåðîâ (NK-êëåòîê) ïðè ðåöèäèâå ÍÑÌÈ [1,2,12]. Íåñêîëüêî ðàáîò ïîêàçàëè òàêæå in vitro óâåëè÷åííóþ ìèòîãåíñòèìóëèðîâàííóþ ïðîäóêöèþ Èë-2, Èë-4 è IFN- g ëèìôîöèòàìè äåòåé ñî ñòåðîèä÷óâñòâèòåëüíûì ÍÑ [11,13]. Ïîâûøåííûå óðîâíè Èë-2, IFN- g , ðàñòâîðèìîãî ðåöåïòîðà Èë-2 (SIL-2R) â êðîâè è óäàëåííàÿ ýêñïðåññèÿ IL-2R íà ëèìôîöèòàõ òàêæå íàáëþäàëèñü äðóãèìè àâòîðàìè ïðè ðåöèäèâå ýòîãî çàáîëåâàíèÿ [1,4,5,12]. Ïðîòèâîïîëîæíûå ðåçóëüòàòû áûëè ïîëó÷åíû Hui-Kim Yap et al. (1999). Ýòè èññëåäîâàòåëè íå íàøëè ïîâûøåíèÿ ýêñïðåññèè ìÐÍÊ Èë-2, IFN- g in vitro èíãèáèöèþ ñåêðåöèè VPF â êîíêàíàâàëèí À-ñòèìóëèðîâàííûõ ÏÌÊ ïîñëå ââåäåíèÿ ðåêîìáèíàíòíîãî ÷åëîâå÷åñêîãî Èë-10 [7]. Êîìáèíàöèÿ äâóõ öèòîêèíîâ (Èë-10 è Èë-13, Èë-10 è Èë-4) ñïîñîáñòâîâàëà ïîòåíöèàëüíîé ñèíåðãè÷åñêîé ñóïðåññèè ýòîãî ôàêòîðà [8,9].

    32. Ãëîìåðóëÿðíîå âîñïàëåíèå è èíòåðëåéêèí
    Interleukin10 inhibits vascular permeability factor release by perypheral bloodmononuclear cells in patients with lipoid nephrosis. Nephron 1997; 75154-159.
    http://www.dialysis.ru/magazin/3_2000/glom.htm
    Glomerular inflammation and interleukin-10 Ò. V. Vashurina, T.V. Sergeeva g (IFN- g intercellular adhesion molecul ICAM-1, ICAM-2) íà ýíäîòåëèè ñîñóäîâ è íà ìåìáðàíàõ ëèìôîöèòîâ, ìîíîöèòîâ/ìàêðîôàãîâ (LFA-1 - lymphocyte function-related antigen-1 ; MAC-1 - macrohage-1 -receptor ). Óñèëåíèå ýêñïðåññèè è âçàèìîäåéñòâèÿ ìåæäó ICAM-1, ICAM-2 è LFA-1, ÌÀÑ-1 ñòèìóëèðóåòñÿ ïðîâîñïàëèòåëüíûìè Èë-1, ôàêòîðîì íåêðîçà îïóõîëè- a (TNF- a) , IFN- g. Äàííûå ïðîöåññû ïîâûøàþò ïðèëèïàíèå ìîíîöèòîâ, ëèìôîöèòîâ ê ýíäîòåëèþ è èõ ïðîíèêíîâåíèå â êëóáî÷åê è èíòåðñòèöèé. Íîâûå âîñïàëèòåëüíûå êëåòêè ïðèâëåêàþòñÿ â èíôèëüòðàò çà ñ÷åò íàêîïëåíèÿ â íåì ìîíîöèòàðíûõ õåìîàòòðàêòàíòíûõ ïðîòåèíîâ, òàêæå ïîâûøàþùèõ ýêñïðåññèþ ICAM-1. Àêòèâèðîâàííûå ìîíîöèòû/ìàêðîôàãè è, â ìåíüøåé ñòåïåíè, ìåçàíãèàëüíûå êëåòêè ñòàíîâÿòñÿ îñíîâíûìè èñòî÷íèêàìè ëîêàëüíîé ãèïåðïðîäóêöèè è ëîêàëüíîãî àóòîêðèííîãî/ïàðàêðèííîãî äåéñòâèÿ ïðîâîñïàëèòåëüíûõ öèòîêèíîâ (Èë-1, TNF- a b - TGF- b , òðîìáîöèòàðíîãî ôàêòîðà ðîñòà - PDGF è äð.), ïîääåðæèâàþùèõ ãëîìåðóëÿðíîå âîñïàëåíèå.  äàëüíåéøåì ôîðìèðîâàíèå ðàçíîîáðàçíûõ ìîðôîëîãè÷åñêèõ âàðèàíòîâ Í â îñíîâíîì îïðåäåëÿåòñÿ âûðàæåííîñòüþ ïðîëîíãèðîâàííûõ íåêîíòðîëèðóåìûõ ïðîöåññîâ ñâîáîäíîðàäèêàëüíîãî áèîëîãè÷åñêîãî îêèñëåíèÿ ñ íàêîïëåíèåì òîêñè÷íûõ ìåòàáîëèòîâ àðàõèäîíîâîé êèñëîòû, à òàêæå ñîîòíîøåíèåì ñòåïåíè ïðîëèôåðàöèè ìåçàíãèàëüíûõ, ýíäîòåëèàëüíûõ êëåòîê è íàêîïëåíèÿ ýêñòðàöåëëþëÿðíîãî ìàòðèêñà (ÝÖÌ). in vivo in vitro ñ îïðåäåëåííûìè êëåòî÷íûìè êóëüòóðàìè, à òàêæå â ðåçóëüòàòå íåïîñðåäñòâåííûõ èññëåäîâàíèé ó áîëüíûõ ñ ïðîëèôåðàòèâíûìè ãëîìåðóëîíåôðèòàìè, IgA-íåôðîïàòèåé, ÔÑÑ, ïîäîñòðûì ãëîìåðóëîíåôðèòîì, âîë÷àíî÷íûì íåôðèòîì óäàëîñü óñòàíîâèòü ñòèìóëèðóþùåå âëèÿíèå Èë-1, Èë-6, TNF-

    33. Untitled
    C. lipoid nephrosis. l. Etiology and Pathogenesis. l. Pathogenesis. a. Know the relationshipbetween lipoid nephrosis and focal. segmental glomerulosclerosis.
    http://155.37.1.60/lectures/RU/RULect.htm

    34. References On The Intra-Arterial Administration Of Agents Using
    P4004 Garin EH, Laflam P, Chandler L. Antiinterleukin 8 antibody abolishes effectsof lipoid nephrosis cytokine. Pediatric Nephrology 1998; 12381-385.
    http://www.alzet.com/bibliography/bib_pages/ia.htm
    Home Page References on the Intra-Arterial Administration of Agents Using ALZET Osmotic Pumps (IA-Q1-2003) 1007D; Controls received mp w/ vehicle; peptides. Yang HT, Yan Z, Abraham JA, Terjung RL. VEGF 2002; 14 days; Controls received mp w/ vehicle; cardiovascular; peptides; vehicle was PBS w/ 10% sodium citrate and 1.6% glycerol; sodium citrate used to prevent coagulation; glycerol used to enhance protein stability. 2002; 14 days; controls received mp w/ vehicle; dose response; peptides, cardiovascular; recomb. human FGF used; sodium citrate used to maintain catheter patency; glycerol used to stabilize protein. 2002; 2 weeks; controls received mp w/vehicle; functionality of mp verified by residual volume; peptides; human. recomb fibroblast growth factor used. 2ML4; 28 days; pump diagram (p. 888); 22 g intravenous catheter was inserted into tygon tubing; "implantable osmotic pumps offer an alternative simple delivery method, providing a constant release of soluble agents in a steady-state fashion." (p. 892); controls received mp w/vehicle; good methods (pp. 887-888); cardiovascular; peptides. 2ML1; 5 days; controls received mp w/vehicle; functionality of mp verified by residual volume; heat-stretched PE-10 tubing used; immunology.

    35. Lipoid Nephrosis
    lipoid nephrosis. A Medical Encyclopedia Maryland Medical System. A resourcewith information on over 4000 medical topics including lipoid nephrosis.
    http://www.marylandophthalmology.com/medical-terms/01322.htm
    Lipoid nephrosis
    A Medical Encyclopedia Article provided by North Arundel Hospital A resource with information on over 4000 medical topics including: Lipoid nephrosis
    Previous
    Next

    36. Renal Pathology
    Renal Pathology. 1. All of the following statements are true with regards tolipoid nephrosis Except 34. Minimal change disease (lipoid nephrosis). 35.
    http://pathology.hscbklyn.edu/renal.htm
    Renal Pathology 1. All of the following statements are true with regards to lipoid nephrosis Except 1. There is evidence that loss of the normally negative glomerular capillary wall
    polyanionic charge is one contributing factor in the increased permeability 2. The detachment of visceral epithelial cells contributes to the increased
    permeability 3. Recent evidence suggests that activation of the membrane-attack complex of
    complement (C5b-9) is a possible cause of the increased permeability 4. Ultrastructurally, there is observed uniform and diffuse loss of podocyte foot
    processes
    2. All of the following statements are true of membranous glomerulonephritis (MGN) Except 1. MGN is characterized microscopically by the presence of subepithelial
    immunoglobulin-containing deposits along the glomerular capillary wall 2. In well-developed (advanced) cases, diffuse thickening of the glomerular
    capillary wall is characteristic 3. The increased permeability of the glomerular capillary wall is due to the
    infiltration and action of neutrophils and monocytes 4. MGN may occur in association with epithelial tumors such as carcinoma of the

    37. Respuesta A Los Esteroides En El Síndrome Nefrótico Idiopático
    Translate this page P, Lee JC, Rosenan W. lipoid nephrosis in 31 adult patients renal biopsy studyby ligth, electron and fluorescence microscopy with experience in treatment.
    http://www.nefrored.net/nefrotic3.htm
    Respuesta a los esteroides en el síndrome nefrótico idiopático
    Dr. Sandalio Durán Álvarez y Dr. Mario Valdés Mesa Profesor Consultante de Pediatría. Facultad de Ciencias Médicas "Enrique Cabrera". Secretario General del Instituto Superior de Ciencias Médicas de La Habana.
    Especialista de I Grado en Pediatría. Asistente de Pediatría.
    RESUMEN
    S
    Descriptores DeCS: SINDROME NEFROTICO/quimioterapia; PREDNISONA/uso terapéutico.
    SUMMARY Subject headings: NEPHROTIC SYNDROME/drug therapy; PREDNISONE/therapeutic use El síndrome nefrótico idiopático (SNI) es una entidad clínica que se caracteriza por proteinuria masiva, hipoalbuminemia, hiperlipidemia y edema. Hísticamente tiene alteraciones no específicas del glomérulo, con inclusion de la lesión mínima (LM), la glomeruloesclerosis focal segmentaria (GFS) y la proliferación mesangial difusa (PMD). Estos hallazgos están asociados con la fusión de los procesos basales podocitarios en la microscopia electrónica y ausencia de depósitos significativos de inmunoglobulinas y complemento. La prednisona se considera la droga de elección para el tratamiento del niño con SNI.

    38. ICD-9-CM From Code 580
    glomerulonephritis. 581.3 With lesion of minimal change glomerulonephritisFoot process disease; lipoid nephrosis; Minimal change glomerular
    http://www.cpmc.columbia.edu/homepages/hripcsa/icd9/1tabular580.html
    NEPHRITIS, NEPHROTIC SYNDROME, AND NEPHROSIS (580-589)
    • Excludes: hypertensive renal disease (403.00-403.91)
  • 580 Acute glomerulonephritis
    • Includes: acute nephritis
    • 580.0 With lesion of proliferative glomerulonephritis
      • Acute (diffuse) proliferative glomerulonephritis
      • Acute poststreptococcal glomerulonephritis
    • 580.4 With lesion of rapidly progressive glomerulonephritis
      • Acute nephritis with lesion of necrotizing glomerulitis
    • 580.8 With other specified pathological lesion in kidney
      • 580.81 Acute glomerulonephritis in diseases classified elsewhere
        • Code first underlying disease, as:
          • infectious hepatitis (070.0-070.9)
          • mumps (072.79)
          • subacute bacterial endocarditis (421.0)
          • typhoid fever (002.0)
        • 580.89 Other
          • Glomerulonephritis, acute, with lesion of:
            • exudative nephritis
            • interstitial (diffuse) (focal) nephritis
          • 580.9 Acute glomerulonephritis with unspecified pathological lesion in kidney
            • Glomerulonephritis: specified as acute
              • NOS specified as acute
              • hemorrhagic specified as acute
            • Nephritis specified as acute
            • Nephropathy specified as acute
          • 581 Nephrotic syndrome
            • 581.0 With lesion of proliferative glomerulonephritis
  • 39. Lipoid Nephrosis
    lipoid nephrosis. A Medical Encyclopedia Article provided by Kernan Hospital. A resourcewith information on over 4000 medical topics including lipoid nephrosis.
    http://www.kernanhospital.com/medical-terms/01322.htm
    Lipoid nephrosis
    A Medical Encyclopedia Article provided by Kernan Hospital A resource with information on over 4000 medical topics including: Lipoid nephrosis
    Previous
    Next

    40. Roche Lexikon Medizin (4. Aufl.) - Lipoidnephrose
    Translate this page Lipoid nephrose. engl. lipoid nephrosis. glomeruläre Minimalveränderungen.Verwandte Themen. glomeruläre Minimalveränderungen.
    http://www.gesundheit.de/roche/ro22500/r22648.html

    A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

    Page 2     21-40 of 85    Back | 1  | 2  | 3  | 4  | 5  | Next 20

    free hit counter